BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 16763157)

  • 1. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.
    Potteaux S; Combadière C; Esposito B; Lecureuil C; Ait-Oufella H; Merval R; Ardouin P; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1858-63. PubMed ID: 16763157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice.
    Potteaux S; Esposito B; van Oostrom O; Brun V; Ardouin P; Groux H; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1474-8. PubMed ID: 15178562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice.
    Xanthoulea S; Gijbels MJ; van der Made I; Mujcic H; Thelen M; Vergouwe MN; Ambagts MH; Hofker MH; de Winther MP
    Cardiovasc Res; 2008 Nov; 80(2):309-18. PubMed ID: 18628255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model.
    Albrecht C; Preusch MR; Hofmann G; Morris-Rosenfeld S; Blessing E; Rosenfeld ME; Katus HA; Bea F
    Cardiovasc Res; 2010 May; 86(2):321-9. PubMed ID: 20110335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow-derived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice.
    Pennings M; Hildebrand RB; Ye D; Kunne C; Van Berkel TJ; Groen AK; Van Eck M
    Cardiovasc Res; 2007 Oct; 76(1):175-83. PubMed ID: 17560559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression.
    Valenta DT; Ogier N; Bradshaw G; Black AS; Bonnet DJ; Lagrost L; Curtiss LK; Desrumaux CM
    Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1572-8. PubMed ID: 16675720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice.
    Babaev VR; Yancey PG; Ryzhov SV; Kon V; Breyer MD; Magnuson MA; Fazio S; Linton MF
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1647-53. PubMed ID: 15947238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-1 deficiency in bone marrow cells increases early atherosclerosis in apolipoprotein E- and low-density lipoprotein receptor-null mice.
    Babaev VR; Ding L; Reese J; Morrow JD; Breyer MD; Dey SK; Fazio S; Linton MF
    Circulation; 2006 Jan; 113(1):108-17. PubMed ID: 16380543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis.
    de Nooijer R; Bot I; von der Thüsen JH; Leeuwenburgh MA; Overkleeft HS; Kraaijeveld AO; Dorland R; van Santbrink PJ; van Heiningen SH; Westra MM; Kovanen PT; Jukema JW; van der Wall EE; van Berkel TJ; Shi GP; Biessen EA
    Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):188-94. PubMed ID: 19095996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development.
    Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice.
    Van Eck M; Ye D; Hildebrand RB; Kar Kruijt J; de Haan W; Hoekstra M; Rensen PC; Ehnholm C; Jauhiainen M; Van Berkel TJ
    Circ Res; 2007 Mar; 100(5):678-85. PubMed ID: 17293475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice.
    Whitman SC; Rateri DL; Szilvassy SJ; Yokoyama W; Daugherty A
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1049-54. PubMed ID: 14988092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development.
    Vikstedt R; Ye D; Metso J; Hildebrand RB; Van Berkel TJ; Ehnholm C; Jauhiainen M; Van Eck M
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):578-86. PubMed ID: 17170377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage-specific expression of mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Matthijsen RA; de Winther MP; Kuipers D; van der Made I; Weber C; Herias MV; Gijbels MJ; Buurman WA
    Circulation; 2009 Apr; 119(16):2188-95. PubMed ID: 19380618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice.
    van Es T; van Puijvelde GH; Ramos OH; Segers FM; Joosten LA; van den Berg WB; Michon IM; de Vos P; van Berkel TJ; Kuiper J
    Biochem Biophys Res Commun; 2009 Oct; 388(2):261-5. PubMed ID: 19660432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice.
    Parks BW; Lusis AJ; Kabarowski JH
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2703-9. PubMed ID: 16990555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucocyte cathepsin K affects atherosclerotic lesion composition and bone mineral density in low-density lipoprotein receptor deficient mice.
    Guo J; Bot I; de Nooijer R; Hoffman SJ; Stroup GB; Biessen EA; Benson GM; Groot PH; Van Eck M; Van Berkel TJ
    Cardiovasc Res; 2009 Feb; 81(2):278-85. PubMed ID: 19015136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.
    Schneider JG; Zhu Y; Coleman T; Semenkovich CF
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2699-706. PubMed ID: 17951320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.